Ratings LANXESS AG

Equities

LXS

DE0005470405

Market Closed - Xetra Other stock markets 11:35:03 2024-04-26 am EDT			5-day change	1st Jan Change
25.77 ^EUR	+0.04%		-0.31%	-9.16%

Apr. 26	LANXESS AG : Barclays reiterates its Neutral rating	ZD
Apr. 19	LANXESS AG : Berenberg reiterates its Buy rating	ZD

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company appears to be poorly valued given its net asset value.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's earnings growth outlook lacks momentum and is a weakness.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
The company is in debt and has limited leeway for investment
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Over the past twelve months, analysts' opinions have been revised negatively.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
LANXESS AG	-9.16%	2.38B	A
SHIN-ETSU CHEMICAL CO., LTD.	-0.19%	74.89B	B
BASF SE	+0.09%	46.52B	A-
DUPONT DE NEMOURS, INC.	-4.19%	30.82B	C
PIDILITE INDUSTRIES LIMITED	+9.85%	18.19B	B
BRENNTAG SE	-10.05%	11.54B	B
SYENSQO SA/NV	-8.09%	9.73B	-
ASAHI KASEI CORPORATION	+2.79%	9.4B	A-
SRF LIMITED	+6.35%	9.37B	C-
MITSUBISHI CHEMICAL GROUP CORPORATION	+3.85%	8.11B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes